Investing
Morning Analyst Calls Briefing for Monday, November 14, 2022
Published:
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Advanced Micro (AMD) upgraded to Buy from Neutral at UBS; tgt raised to $95
> Advanced Micro (AMD) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $100
> Dominion Energy (D) upgraded to Neutral from Sell at Goldman; tgt lowered to $69
> MacroGenics (MGNX) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $16
> Medical Properties Trust (MPW) upgraded to Buy from Neutral at BofA Securities; tgt raised to $16
> Occidental Petro (OXY) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $74
> Veris Residential (VRE) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $18
Downgrades:
> Algonquin Power & Utilities (AQN) downgraded to Hold from Buy at Desjardins
> Algonquin Power & Utilities (AQN) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $11
> Algonquin Power & Utilities (AQN) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $12
> Archaea Energy (LFG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $26
> CGI Group (GIB) downgraded to Hold from Buy at Societe Generale
> Chart Industries (GTLS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $148
> CytomX Therapeutics (CTMX) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $2.60
> Dr. Reddy’s (RDY) downgraded to Underperform from Neutral at Credit Suisse
> EQRx (EQRX) downgraded to Underweight from Neutral at JP Morgan
> Essex Property (ESS) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $233
> Global Payments (GPN) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $118
> Grainger (GWW) downgraded to Peer Perform from Outperform at Wolfe Research
> Hasbro (HAS) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $42
> Lyell Immunopharma (LYEL) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $7
> NETSTREIT (NTST) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $21
> Neurocrine Biosciences (NBIX) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $130
> NIO (NIO) downgraded to Hold from Buy at China Renaissance; tgt lowered to $12.30
> Orsted A/S (DNNGY) downgraded to Neutral from Buy at Goldman
> Sabra Health Care REIT (SBRA) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $13
> Spirit Realty Capital (SRC) downgraded to Neutral from Buy at BofA Securities; tgt raised to $43
> Teleperformance (TLPFY) downgraded to Buy from Conviction Buy at Goldman
> Teva Pharma (TEVA) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $10
Others:
> Bunzl PLC (BZLFY) assumed with a Neutral at Credit Suisse
> Cboe Global Markets (CBOE) initiated with a Neutral at Redburn
> Intertek Group (IKTSY) assumed with an Outperform at Credit Suisse
> Janux Therapeutics (JANX) initiated with an Outperform at William Blair
> NASDAQ (NDAQ) initiated with a Neutral at Redburn
> Prime Medicine (PRME) initiated with a Buy at Jefferies; tgt $25
> Prime Medicine (PRME) initiated with a Neutral at Goldman; tgt $22
> Prime Medicine (PRME) initiated with an Equal-Weight at Morgan Stanley; tgt $23
> Prime Medicine (PRME) initiated with an Overweight at JP Morgan; tgt $27
> Swiss Life (SZLMY) assumed with a Neutral at Credit Suisse
Research calls posted earlier this morning are available here.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
